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Background:Mutations in plasma membrane Ca2-ATPase (PMCA) isoform 3 and in laminin subunit 1 have previously
been linked to ataxic phenotypes.
Results: A novel PMCA3 missense mutation co-occurring with a compound heterozygous mutation in laminin subunit 1
impaired cellular Ca2 homeostasis.
Conclusion: The two mutations could work synergistically to generate the disease phenotype.
Significance: A digenic mechanism could be responsible for this case of cerebellar ataxia.
The particular importance of Ca2 signaling to neurons
demands its precise regulation within their cytoplasm. Isoform
3 of the plasma membrane Ca2 ATPase (the PMCA3 pump),
which is highly expressed in brain and cerebellum, plays an
important role in the regulation of neuronal Ca2. A genetic
defect of the PMCA3 pump has been described in one family
with X-linked congenital cerebellar ataxia. Here we describe a
novel mutation in the ATP2B3 gene in a patient with global
developmental delay, generalized hypotonia and cerebellar
ataxia. The mutation (a R482H replacement) impairs the Ca2
ejection function of the pump. It reduces the ability of the pump
expressed inmodel cells to control Ca2 transients generated by
cell stimulation and impairs its Ca2 extrusion function under
conditions of low resting cytosolic Ca2 aswell. In silico analysis
of the structural effect of themutation suggests a reduced stabi-
lization of the portion of the pump surrounding the mutated
residue in the Ca2-bound state. The patient also carries two
missense mutations in LAMA1, encoding laminin subunit 1.
On the basis of the family pedigree of the patient, the presence of
both PMCA3 and laminin subunit 1 mutations appears to be
necessary for the development of the disease. Considering the
observeddefect incellularCa2homeostasisandtheprevious find-
ing that PMCAs act as digenic modulators in Ca2-linked pathol-
ogies, thePMCA3dysfunctionalongwithLAMA1mutationscould
act synergistically to cause the neurological phenotype.
Ca2 regulates most of the activities of eukaryotic cells,
therefore, it must be very precisely regulated in the cell ambient
in both time and space (1, 2). A number of mechanisms con-
tribute to the regulation of cell Ca2, from soluble proteins that
reversibly bind it, to protein systems that mediate its transport
acrossmembranes. A distinctive property ofCa2 as a carrier of
cellular signals is ambivalence: if its precise regulation fails,
Ca2 becomes amessenger of cell discomfort or even death (2).
Unfortunately, failures of regulation occur in numerous disease
cases, causing various degrees of cellular dysfunction. Ca2-
ATPases (Ca2 pumps) are of special importance in the process
of Ca2 control: their malfunctioning is a frequent causative
agent in important disease states.
Since neurons are particularly dependent on the perfect reg-
ulation of their own Ca2 (3), a number of neuronal diseases
reflect the incorrect functioning of the Ca2 controlling sys-
tems. Among these disease states, those linked to defects of the
plasma membrane Ca2 ATPase (PMCA)6 pumps are becom-
ing increasingly important. Inmammals, PMCA pumps are the
products of 4 genes. The 4 basic isoforms are organized in the
plasmamembrane with 10 transmembrane domains and a long
cytosolic C-terminal tail that contains the regulatory domains
of the enzyme (4). 2 of the 4 basic isoforms (PMCA2 and -3)
have tissue-restricted distribution, and are particularly abun-
dant in the brain and the cerebellum. They have high affinity for
calmodulin, which interacts with the cytosolic C-terminal tail
* This work was supported by the University of Padova (local grants (to-
M. B.), Progetto Giovani GRIC128SP0 (to T. C.), and Progetto di Ateneo
CPDA115047/11 (to R. L.)).
1 Supported by the University of Padova (Progetto Giovani GRIC128SP0,
Bando 2012).
2 Both authors contributed equally to this work.
3 Towhomcorrespondencemaybe addressed: Dept. of Biology, University of
Padova, 35131 Padova, Italy. E-mail: marisa.brini@unipd.it.
4 Towhomcorrespondencemaybe addressed:Dept. of Pediatrics, Divisionof
Genetics and Genomic Medicine, Washington University in St Louis, St
Louis, MO 63110-1093. E-mail: Shinawi_M@kids.wustl.edu.
5 Towhom correspondencemay be addressed: Venetian Institute of Molecu-
larMedicine (VIMM), 35131 Padova, Italy. E-mail: ernesto.carafoli@unipd.it.
6 The abbreviations used are: PMCA, plasma membrane Ca2 ATPase; ER,
endoplasmic reticulum; SOCE, store-operated Ca2 entry; InsP3, inositol
1,4,5 trisphosphate.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 26, pp. 16132–16141, June 26, 2015
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
16132 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 26•JUNE 26, 2015
 at Bibl Biologico-M
edica on N
ovem
ber 14, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
of the pumps, removing it from binding sites next to the active
center of the pumps, relieving the state of auto-inhibition (4).
PMCA2 and PMCA3 concentrate in the cerebellum with
complementary distribution: PMCA3 is mostly associated with
the axonal terminal of granule neurons, while PMCA2 is par-
ticularly abundant in Purkinje dendrites. PMCA3 is also prom-
inently expressed in the choroid plexus (5), and a particular
splice variant of PMCA2 is located in the stereocilia of the outer
hair cells of the inner ear (6). Genetic defects of the PMCA
pumps have been described for PMCA2 and PMCA3. A series
of mutations of the former in mice and humans cause deafness
(7–9). Interestingly, the deafness phenotype was not the only
associated phenotype: one of the PMCA2-defective mice also
had prominent ataxic symptoms (10). The PMCA2 knock-out
mice exhibited ataxic phenotype, with cerebellar dysfunctions
associated with shrunken Purkinje neurons dendrites and
reduced firing frequency (11). As for PMCA3, amissensemuta-
tion of a residue in the C-terminal calmodulin-binding domain
has been recently identified and studied in a family with
X-linked congenital cerebellar ataxia associated with cerebellar
atrophy (12). This mutation reduced the ability of the PMCA3
pump to restore the concentration of Ca2 to baseline after the
transient increase induced by stimulation with an inositol 1,4,5
trisphosphate (InsP3) generating agonist, which induced Ca2
release from intracellular stores.
In the present study we describe a patient with global devel-
opmental delay, generalized hypotonia and cerebellar ataxia
associatedwith a novelmissensemutation in the gene encoding
the PMCA3 pump. We have analyzed possible Ca2 handling
defects associated with the mutation by expressing the mutant
pump in model cells and have found that both the Ca2 extru-
sion under resting cell conditions, and the control of cytosolic
Ca2 transients generated upon cell stimulation were compro-
mised. The proband also carried twomissensemutations in the
LAMA1 gene coding for laminin subunit 1. This is an inter-
esting finding as it recalls the digenic mechanism described in
the case of hereditary human deafness, where the mutations of
the PMCA2 pump were accompanied by mutations of cad-
herin-23, a protein involved in themechanoelectrical transduc-
tion process (7, 9).
The presence of two LAMA1 genetic mutations in our pro-
band is of particular interest, as a phenotype of cerebellar dys-
plasia with cysts (with and without retinal dystrophy) has
recently been described in 7 probandswho carried homozygous
or compound heterozygous mutations, or deletion mutations
in the LAMA1 gene which induce protein truncation (13). Our
patient displays clinical features of X-linked cerebellar ataxia.
His brain imaging showed unusual vertical course of the
straight sinus with inferior location of the torcula consistent
with a relatively small posterior fossa. Since the same PMCA3
mutation was found in the healthy maternal grandfather, the
PMCA3 pump defect is evidently not sufficient to cause the
neurological phenotype per se. On the other hand, since no
individual harboring exclusively the two LAMA1mutations has
been identified so far, it is not possible to state conclusively that
the phenotype in our proband could be entirely associated with
the double LAMA1 defect. Considering the increasing number
of reports implicating PMCA pump defects in neuronal dis-
eases and, especially, the previous finding of the digenic origin
of the phenotype in patients carrying PMCA2 mutations (7), it
is plausible to suggest that the PMCA3mutation could act as an
essential digenic modulator in the development of cerebellar
dysgenesis associated to LAMA1mutations.
Experimental Procedures
Molecular Analysis—Exome sequencing was performed by
GeneDx (Gaithersburg, MD) using Agilent SureSelect XT2 All
Exon V4 Kit and Illumina HiSeq 2000 with 100bp paired-end
reads. Sequence was aligned to the UCSC build hg19 reference
sequence. Mean depth of coverage was 121x with quality
threshold of 98.9%. GeneDx’s XomeAnalyzer was used to eval-
uate sequence changes found between the proband, parental
samples, and reference. Di-deoxy sequencing was used for con-
firmation of reported mutations.
DNA Constructs—Full-length (PMCA3b) and truncated
(PMCA3a) variants of PMCA3 R482H mutant were obtained
by site-directedmutagenesis on cDNA templates of human ori-
gin cloned in the pcDNA3 vector. Mutagenesis was performed
according to themanufacturer’s standard protocol (Stratagene,
Cedar Creek, TX) using the following primers R482H-for
5-GGCACGCTCACCACCAACCATATGACCGTGGTCC-
AGTCC-3; R482H-rev 5- GGACTGGACCACGGTCATAT-
GGTTGGTGGTGAGCGTGCC-3. To create yeast expres-
sion vectors wild-type human PMCA3b cDNA was amplified
by PCR using high-fidelity DNA polymerase (KAPA Biosys-
tems) and the following primers: PMCA3b-for: 5-GCTT-
GGTACCGAGCTCGGATCCGTCGACATGGGTGACAT-
GGCGAACAGTTCC-3; PMCA3b-rev: 5-CATGCT CGAG-
CGGCCGCTTAGAGGGATGTCTCCATGCTGTGG-3. The
wild-type PMCA3b-pYES2 vector was used a template to gen-
erate the R482H PMCA3b-pYES2 vectors and the other two
control mutants. The constitutively inactive PMCA3 D459A
mutant was created by PCR using the following primers:
D459A-for: 5-ACAGCCATCTGTTCTGCCAAGACAGGC-
ACACTC-3, and D459A-rev 5-GAGTGTGCCTGTCTT
GGCAGAACAGATGGCTGT-3. The constitutively active
PMCA3-Cter was created by deleting the last 158 residues at
its C terminus by PCR amplification of the wt PMCA3b cDNA
template using the PMCA3b-for and the PMCA3C-rev: 5-C-
ATGCTCGAGCGGCCGCTTACTGGCTGGTGGGGATA-
GTGGC-3 primers. The PCR products were digested by KpnI
and XhoI restriction enzymes and inserted in the galactose-
inducible pYES2 plasmid (Life Technologies). The mutated
codons are in bold and the restriction sites are underlined. All
the constructs were verified by sequencing. cytAEQ expression
plasmid has been previously described (14).
Cell Cultures and Transfection—HeLa cells were obtained
from ATCC Cell Biology Collection. They were grown in Dul-
becco’s modified Eagle’s medium high glucose (DMEM, Euro-
clone), supplemented with 10% fetal bovine serum (FBS, Euro-
clone), 100 units/ml penicillin and 100 g/ml streptomycin;
12 h before transfection, cells were seeded onto 6-multiwell
plates (for aequorin measurements andWestern blotting anal-
ysis) or 13-mm glass coverslips (for immunocytochemistry
analysis) and allowed to grow to 60–80% confluence. For Ca2
measurements HeLa cells were co-transfected with the
PMCA3Mutation and Cerebellar Ataxia
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aequorin construct (cytAEQ) and the empty vector (mock) or
PMCA3 expressing plasmids in a 1:2 ratio with the calcium-
phosphate procedure as previously described (15). 6 g of total
plasmid DNAwere used for the transfection of the cells in each
well of the 6-multiwell plate and 4g for each 13-mmcoverslip.
Western Blotting Analysis—48 h after transfection Hela cells
were washed on ice with Ca2/Mg2-free Dulbecco Phos-
phate-Buffered Saline (DPBS, Euroclone). Cell lysates were
obtained according to Ref. 12, resuspended in Sample Buffer
(82mMTris, 10.5% glycerol, 2% SDS, 0.002% Bromphenol Blue,
pH 6.8) supplemented with DTT (100 mM) and urea (125
mg/ml) and incubated for 10min at 37 °C. Total protein lysates
from yeast cells carrying the different PMCA vectors have been
prepared according to (16) and finally resuspended in Sample
Buffer (0.1 MTris-Cl pH 8.8; 2% SDS; 50mMDTT; 10% glycerol;
0.01% Bromphenol Blue).
The total protein content was determined by the Bradford
assay (Bio-Rad). Samples were loaded on a 8% SDS-PAGETris/
HCl gel, transferred onto PVDF membranes (Bio-Rad). The
membrane was blocked for 1 h at room temperature using 5%
nonfat dried milk (NFDM) in TBST (20 mM Tris-HCl, pH 7.4,
150 mM NaCl, 0.05% Tween-20) and incubated overnight with
the specific primary antibody at 4 °C. Monoclonal non isoform
specific anti-PMCA clone 5F10, 1:1000 (Thermo Scientific),
rabbit polyclonal anti-PMCA3 antibody, 1:1000 (affinity BioRe-
agents) and monoclonal anti- actin, 1:30000 (Sigma) primary
antibodies were used. Detection was carried out by incubation
with secondary HRP-conjugated anti-mouse or anti-rabbit IgG
antibody (Santa Cruz Biotechnology) for 1.5 h at room temper-
ature. The proteins were visualized by the chemiluminescent
reagent Immobilon Western (Millipore).
Immunocytochemistry Analysis—36 h after transfection,
HeLa cells were processed for immunofluorescence. The cells
were washed twice with PBS (140 mM NaCl 2 mM KCl 1.5 mM
KH2PO4 8 mM Na2HPO4, pH 7.4), fixed for 20 min in 3.7%
formaldehyde and washed three times with PBS. The cells were
then permeabilized in 0.1% Triton X-100 in PBS, followed by a
1-h wash with 1% gelatin (type IV, from calf skin) in PBS. Cells
were then incubated for 1 h at 37 °C in a wet chamber with a
monoclonal antibody recognizing all pump isoforms (5F10;
Thermo Scientific) or with a rabbit polyclonal anti-PMCA3
antibody (affinity BioReagents) at a 1:100 dilution in PBS. Stain-
ing was carried out with Alexa Fluor 488-labeled anti-mouse or
anti-rabbit secondary antibody (Molecular Probes, Carlsbad,
CA) at a 1:50 dilution in PBS. Fluorescence was analyzed with a
Leica SP5 confocal microscope and analyzed by ImageJ
software.
Ca2Measurements with Recombinant Aequorin—Cytosolic
Ca2 concentration measurements were carried out in a Per-
kin-Elmer Envision plate reader equipped with a two-injectors
unit. The day before the Ca2 measurements, the transfected
cells were plated onto 96-well plate. Recombinant cytAEQ was
reconstituted by incubating HeLa cells for 1–3 h with 5 M
coelenterazine inmodifiedKrebs Ringer Buffer (KRB,NaCl 135
mM, KCl 5 mM, KH2PO4 400 mM, MgSO4 1 mM, Hepes 20 mM,
pH7.4). In some experiments the intracellular Ca2 storeswere
first depleted by incubating the cells for 3 min in KRB contain-
ing 1 mM EGTA and supplemented with 1M thapsigargin and
100 M histamine before Ca2 recording. After reconstitution
the cells were placed in 70l of KRB supplemented as indicated
in the figures and luminescence from each well was measured
for 1 min. According to the experiment, histamine 100 M or
CaCl2 3mM at the final concentration were injected to generate
Ca2 transients. The experiments were terminated by lysing
the cells with 100 M digitonin in a hypotonic Ca2-rich solu-
tion (10 mM CaCl2 in H2O) to discharge the remaining recon-
stituted aequorin pool. Output data were analyzed and cali-
brated with a custom made macro-enabled Excel workbook.
Data are reported as means  S.E. Statistical differences were
evaluated by Student’s two-tailed t test for unpaired samples. A
p value of0.05 was considered statistically significant.
Functional Complementation Assay in K616 Yeast Cells—
Saccharomyces cerevisiae strain K616 (Mat ; pmr1::HIS3;
pmc1::TRP1; cnb1::LEU2; ade2; ura3) (17) has been used to per-
form the Ca2-ATPase functional complementation assays
(18). Briefly, yeast cells were transformed by standard protocols
(19) with different pYES2-derived vectors, carrying either wild-
type or mutagenized PMCA3 cDNAs. Positive clones were
selected on SD medium (6.7% yeast nitrogen base with ammo-
nium sulfate, 2% glucose), lacking uracil and added with 10 mM
CaCl2. Functional complementation assays (repeated for at
least 3–5 independent clones) have been performed by growing
yeast cells in SDCaCl2 until mid-log phase, when similar
number of yeast cells were serially diluted and spotted on min-
imal medium containing glucose (pYES2-PMCA3 repression)
or galactose (pYES2-PMCA3 induction) as carbon source.
Addition of 10 mM CaCl2 or 10 mM EGTA to glucose or galac-
tose medium reflects permissive and non-permissive condi-
tions for yeast K616 viability, respectively.
Bioinformatics Analysis—SIFT, the polymorphism pheno-
typing program Poly-Phen and PMut. Computer algorithms
were used to analyze the possible impact of LAMA1 missense
mutations. For evolutionary conservation, the LAMA1 and
PMCA3 protein sequences were downloaded from NCBI, and
the alignments were obtained from Homologene. The predic-
tion of the PMCA3 pump structure has been performed by
using Swiss-Model on the SERCA pump structures in its Ca2-
free and Ca2-bound state (PDB ID:3W5B and 1SU4, respec-
tively) as a template. The obtained structures were analyzed by
the Pymol software.
Results
Exome Sequencing Revealed the Presence of Mutations in
LAMA1 andATP2B3Genes—The proband is a 6-year-oldmale
presenting with global developmental delay, generalized hypo-
tonia and feeding difficulties. His brainMRI at 10months of age
was normal but repeated imaging at 6 years showed unusual
vertical course of the straight sinus with inferior location of the
torcula, a configuration consistent with a small posterior fossa
and a dysplastic corpus callosum (Fig. 1A). Whole exome
sequencing revealed a maternally inherited hemizygous muta-
tion, p.Arg482His (c.1445GA), in exon 9 in the X-linked
ATP2B3 gene. This mutation has not been reported previously
as a disease-causing mutation nor as a benign polymorphism.
The p.Arg482Hismutationwas not observed in6500 individ-
uals of European and African American ancestry in the NHLBI
PMCA3Mutation and Cerebellar Ataxia
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Exome Sequencing Project. The maternal grandfather, who
reportedly hadnoneurological findings, is a carrier for the same
mutation in theATP2B3 gene. In addition, twomissensemuta-
tions were found in the LAMA1 gene of the proband: a mater-
nally inherited p.Thr2025Met (c.6074CT) in exon 43 and a
paternally inherited p.Arg2381Cys (c.7141CT) in exon 50
(Fig. 1B) (for the nomenclature of the LAMA1 gene mutation,
nucleotide numbering was designated according to reference
sequence in GenBank Accession number NM_005559.3). The
p.Thr2025Metmutation was previously reported in one case of
somaticmutation in lung carcinoma tumor cells (CosmicData-
base ID: COSM708993) but never reported as a disease-causing
mutation nor as a benign polymorphism, and not found in
6500 individuals of European and African American ancestry
in the NHLBI Exome Sequencing Project. The p.Arg2381Cys
mutation, a rare variant (rs142063208; MAF 0.01), was also
reported as somatic mutation in glioblastoma multiforme
tumor cells (20). The effect of the p.Thr2025Met was predicted
as probably damaging only by the Poly-Phen2 algorithm
whereas the p.Arg2381Cys mutation was predicted deleterious
by all algorithms used. Alignment of orthologous protein
sequences revealed that both Thr-2025 and Arg-2381 residues
of laminin subunit 1 and the Arg-428 residue in PMCA3 gene
are well conserved across species (Fig. 1C).
Comparative Analysis of the Ca2 Handling Activity of the
Full Length and Truncated Isoform of WT and R482H PMCA3
Mutant Overexpressed in HeLa Cells—To selectively explore
the ability of the mutated PMCA3 pump to handle cellular
Ca2 fluxes in living cells, we generated a mammalian expres-
sion vector encoding the mutant PMCA3 pump and expressed
it in HeLa cells. The R482H mutation was introduced in the
full-length (PMCA3b) as well as in a C-terminally truncated
(PMCA3a) variant of PMCA3, which is also expressed in
neurons, by site-directed mutagenesis. The full-length and
the C-terminally truncated isoforms of the pumps only differ
in the appearance of a premature stop codon caused by a
shift in the reading frame during the alternative splicing of
the primary transcript that replaces the C-terminal portion
of the pump downstream themiddle of the calmodulin-bind-
ing domain (4).
Western blotting analysis of the transfected HeLa cells was
performed using a non-isoform specific antibody that recog-
nizes all the PMCA variants (5F10) and a rabbit polyclonal anti-
PMCA3antibody. They revealed the presence of pumpbands at
the expected molecular weight of 135 kDa for the full-length
variant and 129 kDa for the truncated variant (Fig. 2, A and B)
with comparable expression levels between the wt and
R482H mutant. The numbers under the bands refer to the
ratio between the intensities of the bands relative to PMCA
and -actin. The increase over the endogenous level was
about 3-fold but, considering that the average transfection
efficiency is about 25%, the overexpressed pump should
exceed the endogenous one by about 12-fold. We are thus
confident that the Ca2 extrusion in PMCA-overexpressing
cells is predominantly due to the exogenous pump. The sub-
cellular localization of the overexpressed wt as well as the
R482H mutants was assessed by immunocytochemistry
analysis. As shown in Fig. 2, C and D, all the pump variants
were correctly targeted to the plasma membrane. Thus, the
R482H mutation did not affect the expression or the local-
ization of the transfected pump. Untransfected cells were
also visible in Fig. 2C (indicated by arrows) and the 5F10
antibody revealed that a portion of both the endogenous and
the overexpressed PMCA pump was present in the intracel-
lular compartments, possibly in the membrane of the endo-
plasmic reticulum (ER). We had previously documented that
FIGURE 1. Phenotype of the proband, pedigree family and multispecies alignment of the LAMA1 and PMCA3 mutations. A, brain imaging of the
proband. Single T1-weightedmidline sagittal imagedemonstratesunusual vertical courseof the straight sinus (arrows)with inferior locationof the torcula. This
configuration is consistent with a small posterior fossa. B, pedigree of the proband’s family showing the mappedmutations. C, multispecies alignment of the
Laminin1 and the PMCA3 amino acids sequences showing that the mutated residues are conserved (bold).
PMCA3Mutation and Cerebellar Ataxia
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the ER-resident pump was not active, and thus it did not
contribute to Ca2 handling (21). The nuclear fluorescence
in Fig. 2D is a spurious signal, since it is also present in
untransfected cells (indicated by arrows) where the PMCA3
isoform was absent.
To study whether R482Hmutation influenced pump activity
we have monitored its ability to counteract the cytosolic Ca2
transients generated upon cell stimulation with an InsP3 gener-
ating agonist, which induced Ca2 release from the intracellu-
lar stores. HeLa cells were co-transfected with the plasmid
encoding the recombinant Ca2-sensitive photoprotein
aequorin (cytAEQ, (14)) and the expression plasmids encoding
the mutant PMCA3 isoforms or the respective wt variant. In
agreement with previous findings (22), the traces (Fig. 2, E and
G) of the cytosolic Ca2 transients generated by the stimulation
with histamine, and their statistical analysis (Fig. 2, F and H),
show that in PMCA3 overexpressing cells the amplitude of the
Ca2 peak, regardless of the a or b splicing variant tested, was
significantly reduced with respect to control cells transfected
only with cytAEQ (peaks values: 1.46  0.04 M n  21 for
control cells, 0.87 0.02M n 19 forwt PMCA3a and, 0.93
0.03 M n  21 for wt PMCA3b). HeLa cells overexpressing
mutant R482H PMCA pumps still displayed Ca2 transients
with reduced amplitude and faster kinetics with respect to con-
trol cells, indicating that the R482H mutation did not abolish
the activity of the pump. However, significant differences in the
peak amplitude were observed with respect to the cells overex-
pressing the wt pump variant (1.05  0.05 M n  17 for the
PMCA3a R482H and 1.30 0.04 M n 22 for the PMCA3b
R482H), indicating that the activity of the pump was compro-
mised. As a consequence, the cells overexpressing the mutated
pumpwere expected to experience amore prolonged retention
of Ca2within the cytoplasm than those overexpressing the wt
pump. This was particularly evident looking at the traces rela-
tive to cells overexpressing the a variant, i.e. the variant which
in resting conditions is more active as it is less auto-inhibited
(Fig. 2E).
Effect of the R482H Mutation on the Ability of PMCA3 to
Selectively Control the Ca2 Swings Generated by the Influx of
Extracellular Ca2 Promoted by the Emptying of the Intracellu-
lar Stores—The Ca2 transients shown in Fig. 2 are the sum of
the Ca2 released from the intracellular stores (endoplasmic
reticulum andGolgi apparatus) and of the Ca2 influx from the
extracellular medium through the store operated Ca2 (SOC)
channels. To evaluate the specific contribution of the overex-
pressed pumps in counteracting Ca2 entry from the extracel-
lular ambient, and to abolish the contribution of Ca2 release
from the intracellular deposits and of its re-uptake by theCa2-
ATPase of the ER (the SERCApump), the cells were pre-treated
for 3 min with a Krebs Ringer Buffer containing the Ca2-
chelating agent EGTA and histamine (to deplete the intracellu-
lar stores) in the presence of the inhibitor of the SERCA pump
thapsigargin. Cytosolic Ca2measurements were initiated in a
Ca2 free medium, then the cells were exposed to 3 mM extra-
cellular Ca2 to generate cytosolic Ca2 transients through the
process of store-operatedCa2 entry (SOCE).Under these con-
ditions, the overexpressed PMCA pumps were forced to work
at their maximal rate. Fig. 3 shows the effect of the overexpres-
sion of the wt and the R482Hmutant pump variants (PMCA3a
in Fig. 3, A–C; PMCA3b in Fig. 3, D–F). The peak of the tran-
sient, which reflected the magnitude of Ca2 influx, was sur-
prisingly significantly higher in cells overexpressing either the
wt or the R482Hmutated pump than in control cells. This pos-
sibly reflected a reduced Ca2-dependent feedback inhibition
of the SOC channels, which in the presence of the overex-
pressed PMCA pump, and thus under condition of local
increased Ca2 extrusion, were exposed to sub-plasma mem-
brane microdomains of reduced Ca2 concentrations or dura-
tion (peak values in M  S.E. were: 6.24  0.32 n  20 for
control cells, 8.54  0.38 n  22 for the wt PMCA3a, 9.31 
0.52 n 20 for R482H PMCA3a and 9.36 0.51 n 20 for wt
PMCA3b, 9.89 0.67 n 20 for the R482H PMCA3b). As the
Ca2 peaks declined, the traces attained a plateau level
(enlarged insets in Fig. 3, A and D), which reflected the average
amount of cytosolic Ca2 concentration in the post-influx
phase, andpermitted a better assessment of the pumpextrusion
ability. The cells overexpressing the wt and mutated PMCA3
variants attained a lower basal Ca2 plateau than control cells,
as they expressed increased pump amount. As for the compar-
ison between wt versus mutated PMCA3 pumps, the average
basal Ca2 concentration values were slightly, but significantly,
higher in cells overexpressing theR482HPMCAmutant pumps
than in those overexpressing the wt variants (Fig. 3C for the
PMCA3a variant. The plateau values in M  S.E. were:
0.56  0.01 n  20 for the wt and 0.64  0.03 n  22 for the
R482H mutant; Fig. 3F for the PMCA3b variant, plateau val-
ues in M  S.E. were: 0.62  0.02 n  18 for wt and 0.72 
0.03 n 22 for the R482Hmutant PMCA3,p	 0.00001). The
results thus confirmed that the introduction of R482Hmuta-
tion in both a and b pump variants impaired their efficiency
in maintaining basal Ca2 levels, causing sustained Ca2
retention in the cytoplasm.
Effect of the R482HMutation on the Basal Activity of PMCA3
Assessed by Functional Complementation Assay in K616 Yeast
Cells—To better evaluate the effect of the R482H mutation on
pump basal activity, i.e. on the activity of the auto-inhibited
state of the pumponly exposed to the nM concentration of Ca2
that prevails in the cytoplasm at rest, a yeast-based functional
assay, which has been previously described, was employed (23).
In this assay, the lethal phenotype of the K616 triple mutant
FIGURE 2.Analysis of the expression of the exogenous pumpvariants and cytosolic Ca2measurements inHeLa cells overexpressing thewt and
the mutant PMCA3 isoforms. A and B, Western blotting. C and D, immunocytochemistry analysis showing the expression level and the intracellular
distribution of the PMCA3 pump in HeLa cells expressing the wt and themutant truncated (a) as well as full-length (b) variants. The PMCA3was revealed
by the mouse monoclonal antibody 5F10 in A and C, and by the rabbit polyclonal anti-PMCA3 antibody in B and D. E–H, cells were co-transfected with
cytAEQ and the expression plasmid for the a (E-F) or the b (G-H) wt as well as themutated PMCA3 variants. Cytosolic Ca2 transients (E–G) were recorded
following 100 M histamine stimulation. The average peak values are shown in (F-H). Bars in panels F and H represent mean [Ca2] values upon
stimulation (M S.E.). ***, p	 0.001; **, p	 0.01; *, p 0.05. The number on the bars indicate the number of independent measurements out of six
independent transfections.
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yeast cells observed in Ca2-free conditions can be rescued by
the ectopic expression of active Ca2 pumps. To test the sys-
tem, two control PMCA3mutants were generated: an ATPase-
dead mutant in which the catalytic aspartate residue of the
pump was replaced with an alanine (PMCA3b D465A), and a
C-terminally truncated PMCA3 mutant lacking nearly the
entire autoinhibitory C-terminal tail (the last 158 C-terminal
residues, PMCA3-Cter). The removal of the C-terminal tail
renders the pump constitutively active, making this variant a
suitable positive control in the assay.
Yeast K616 cells were transformed with the galactose-induc-
ible plasmid pYES encoding the wt pump, or with the PMCA3b
D465A, the PMCA3-Cter, and the PMCA3b R482H pump
variants. Fig. 4A shows the growth controls of yeast trans-
formed with the different PMCA3 constructs in a Ca2-con-
taining permissive medium (glucose CaCl2) or in an induci-
ble Ca2-free medium (galactose EGTA), and Fig. 4B shows
the Western blotting analysis of the PMCA3 pump protein
expression levels.
As expected, the PMCA3b-Cter mutant that lacked the
C-terminal tail, and was thus constitutively active, was able to
fully rescue the viability of K616 yeast cells in the Ca2-de-
pleted medium, whereas the wt PMCA3b, which was auto-in-
hibited, did it only partially (Fig. 4A). Again as expected, the
ATPase-dead PMCA3bD465Amutant failed to rescue the via-
bility of the K616 yeast cells (Fig. 4A). Fig. 4C shows the effect of
the PMCA3bR482Hmutant in comparisonwith the wt and the
constitutively active PMCA3b-Cter variant. The R482H
mutant was clearly defective in the recovery of the viability of
theK616 cells. Themutant pumpdid still permit some recovery
of yeast viability, i.e. it evidently did not completely turn off the
basal, unstimulated activity of the pump. This was in agree-
ment with the results of the experiments on the overexpres-
sion of the mutated pump in HeLa cells that had shown that
the R482H PMCA3mutant, even if defective, was still active.
The Western blot analysis of the total protein extracts from
yeast cells grown in the galactose medium show that all
PMCA3 constructs were expressed in yeast cells at compa-
rable levels (Fig. 4, B and D for the different PMCA3b vari-
ants). The experiments in Fig. 4 thus shows that the defect
induced by the R482H mutation also affected the basal
unstimulated activity of the pump.
In Silico Analysis of the Effects of the R482H Mutation on
PMCA3PumpStructure—In an attempt to understand the con-
sequences of the R482Hmutation on the structure of the pump,
we decided to perform an in silico modeling study using the
SERCA pump 3D structure in the Ca2-free and Ca2-bound
states (PDB ID:3W5B) and (PDB ID: 1SU4) (Fig. 5, A and D,
respectively). The 3D structure defines themembrane sector of
the pump containing 10 helices, and the three large cytosolic
domains: the ATP binding N domain protruding into the cyto-
sol between trans-membrane domains 4 and 5, the P domain
that contains the catalytic Asp (blue dots), and the A domain
(the actuator domain) that performs the de-phosphorylation of
the catalytic Asp-P. During the reaction cycle, a series of con-
formational transformations have been shown to occur in both
the cytosolic and the membrane sectors of the SERCA pump,
the most evident being the transition of the cytosolic portion
from a compact arrangement in the Ca2-free state (Fig. 5A) to
a looser state in its presence (Fig. 5D). A finer analysis of the
structure of the modeled PMCA3 pump identifies glutamate
530 as critical for short-range interactions with the Arg-482
FIGURE 3. Effect of the truncated and full length wt and mutant pump on the influx of Ca2 from the extracellular medium. HeLa cells were co-
transfected with cytAEQ and the PMCA3 constructs, or transfected with cytAEQ only, pretreated with 1 M thapsigargin and 100 M histamine in a buffer
containing 1 mM EGTA for 3 min and perfused in the presence of KRB/Ca2 3 mM to stimulate Ca2 entry from the extracellular ambient. The Ca2 transients
in panel A for the PMCA3a isoform and in panel D for the b variant are characterized by a first peak and a plateau phase (as indicated). Enlargements of the
plateau phases are shown in the insets. Panels B and E show the averaged peak [Ca2] values obtained upon stimulation and panels C and F show the obtained
averaged [Ca2] values of the plateau. Bars representmeans S.E. obtained by averaging the values obtained in at least 18 independentmeasurements from
six independent transfections for each condition. ***, p	 0.001; ns, not significant.
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residue. In the wt PMCA3 pump in the Ca2-free state, Arg-
482 is at a distance of 9.2 Å fromGlu-530 (Fig. 5B), the distance
increasing to 11.6Å if the position 482 is occupied by a histidine
(Fig. 5C). These distances obviously do not permit the interac-
tion between the two residues. However, in the Ca2-bound
state (Fig. 5, E and F), the guanidiniumnitrogens of Arg-482 are
now at a distance from both carboxylic oxygens of Glu-530 that
permits interaction: 2.66Å for each of them (Fig. 5E). The inter-
action could be critical for the stabilization of this portion of the
PMCA3 pump in the Ca2-bound state. However, when posi-
tion 482 becomes occupied by a histidine (Fig. 5F), its nitrogen
lies at a distance of 4.5Å and 4.3Å from the oxygens ofGlu-530,
respectively. These increased distances could well reduce the
stabilization of this portion of the pump in the Ca2-bound
state. The intrinsic pH-dependence of histidinemight also have
a role in the modulation of the stability of this portion of the
pump molecule.
Discussion
Genetic defects of calcium pumps (the Golgi (SPCA) pump,
the sarco(endo)plasmic reticulum (SERCA) pump, and the
plasmamembrane (PMCA) pump) are the cause of a number of
diseases. The hereditary deafness caused by mutations of the
PMCA2 isoform (7, 9) can be associated with ataxic symptoms
(10, 11). An ataxia-causing defect was recently described in
PMCA3 (12). The present contribution describes a second case
of ataxia in which the proband carries a defect in the PMCA3
pump. The defect was evident in both the maximally activated
Ca2 exporting function of the pump and in its resting activity,
in which the pump was expected to be largely auto-inhibited.
The overall malfunction of the enzyme in both the fully active
and in the resting states was not surprising, as the mutation
concerned a residue close to its active center. The in silico anal-
ysis shown in Fig. 5 has offered a plausible molecular rationale
for the inhibitory effect of the mutation.
The finding of a second ataxic proband who carries an
ATP2B3 mutation suggests that defects of the PMCA3 pump
could perhaps be specifically associated to the ataxic pathology.
A peculiar property of PMCA pumps is the phenomenon of
auto-inhibition in the resting, low Ca2 state. It is produced by
the binding of the C-terminal tail of the pump to its main body,
and is relieved by the binding of calmodulin once Ca2 in the
ambient increases. Thus, mutations could positively or nega-
tively affect the auto-inhibition process and/or inhibit the Ca2
exporting function of the pump in the fully active state (24, 25).
It should also bementioned that theCa2 exporting function of
the pump in cells in which the muchmore powerful Na/Ca2
exchanger predominates, e.g. inmuscles and neurons, is ofmar-
ginal importance to the global regulation of cell Ca2 (26), but is
very important to the regulation of Ca2 in the microdomains
surrounding the cytosolic portion of the pump. The PMCA
pump has been shown to be concentrated in the caveolae,
which also contain enzyme supercomplexes that are essential
for cell functions (27, 28). Neurons do not contain caveolae, but
contain functionally equivalent structural microdomains, e.g.
the spines. Pump defects could thus have important conse-
quences for the local regulation of intracellular Ca2 signaling
with very serious deleterious effects on the activity of the cell.
One last important point should be mentioned, as it may be
significant to the role of PMCA pump defects in pathology. As
it has become clear from the studies of hereditary hearing loss,
the mutation in the ATP2B2 gene acted synergistically with a
defect of CDH23 or MYO6 to induce the pathological pheno-
type by a digenic disease-causing mechanism. In the proband
described here, the defect of the PMCA3 pump is not isolated,
as he also carries compound heterozygous mutations in
LAMA1. Interestingly, his maternal grandfather carries the
PMCA3mutation and is apparently healthy, which raises ques-
tions regarding incomplete penetrance secondary to genetic
modifiers.We suggest that the PMCA3mutation, may contrib-
ute or enhance ataxic symptoms in the presence of the two
LAMA1 mutations in our proband. Laminins are extracellular
matrix proteins essential for basement membranes assembly
FIGURE 4. Functional complementation assay in K616 yeast cells. A, serial dilutions and B Western blotting analysis of yeast K616 cells transformed with
pYES2-derived vectors carryingwild-type, D465Amutant, or the C-terminal truncated PMCA3 (PMCA3Cter). Empty vector pYES2 (mock transfected)was used
as negative control. C and D, same as A-B but yeast K616 cells are transformed with pYES2-derived vectors carrying wild-type, R482H mutant, or the
PMCA3Cter. Total protein lysates from yeast cells carrying the indicated pYES2-derived plasmids were probed with anti-PMCA antibody 5F10. Both mono-
meric (*) and dimeric (**) PMCA3 forms were detected.
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(29), and LAMA1 is essential for mouse cerebellar develop-
ment: its deficiency causes a decrease in the proliferation and
migration of granule cells precursors and amarked reduction of
dendritic processes in Purkinje cells (30). Mutations in PMCA3
and LAMA1 could thus work synergistically, and contribute to
the disease phenotype of our proband. This is still a speculative
suggestion since it cannot be excluded that the two LAMA1
mutations would be sufficient per se to cause the phenotype.
The malfunction of the systems that control Ca2 could natu-
rally be expected to have negative consequences for neurons,
given the special importance of Ca2 signaling to them. How-
ever, the synergism between a defect of LAMA1 and that of a
Ca2-related protein is not as immediately obvious as that of
the PMCA2 pump with Ca2-related Cadherin-23 in heredi-
tary deafness. It might be interesting that another laminin, -2
laminin, has recently been shown to be involved in the process
ofmaturation and Ca2 sensitivity of voltage-gated Ca2 chan-
nels (31).
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